These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2018814)

  • 1. Are drugs approved by the FDA safe and risk free?
    Natl Med Leg J; 1991; 2(1):8. PubMed ID: 2018814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are novel drugs more risky for patients than less novel drugs?
    Olson MK
    J Health Econ; 2004 Nov; 23(6):1135-58. PubMed ID: 15556240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal implications of preparing and dispensing approved drugs for unlabeled indications.
    Podell LB
    Am J Hosp Pharm; 1983 Jan; 40(1):111-3. PubMed ID: 6823981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point of law: what are the legal implications of prescribing and administering FDA-approved drugs in nonapproved ways?
    Kaunitz AM
    Hosp Med Staff; 1982 Feb; 11(2):15-8. PubMed ID: 10254209
    [No Abstract]   [Full Text] [Related]  

  • 5. Taking an alternative risk.
    Sveska KJ
    Mich Health Hosp; 1998; 34(6):26-7. PubMed ID: 10187139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When a drug is withdrawn.
    Johnson LJ
    Med Econ; 2005 May; 82(10):68. PubMed ID: 15977763
    [No Abstract]   [Full Text] [Related]  

  • 7. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

  • 9. Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.
    O'Reilly JT
    Food Drug Law J; 2007; 62(3):559-72. PubMed ID: 17915397
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
    Marthaler AL
    Spec Law Dig Health Care Law; 1997 Sep; (223):9-45. PubMed ID: 10173273
    [No Abstract]   [Full Text] [Related]  

  • 11. Plaintiff's attorney actively seeking out patients who have used various FDA approved medications and who "may be entitled to compensation for damages caused by these medications".
    South D
    J Miss State Med Assoc; 2000 Nov; 41(11):798-9. PubMed ID: 11107716
    [No Abstract]   [Full Text] [Related]  

  • 12. Legal liability for medical innovation.
    Epstein RA
    Spec Law Dig Health Care (Mon); 1989 May; (123):7-27. PubMed ID: 10292879
    [No Abstract]   [Full Text] [Related]  

  • 13. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 14. Informed consent when using medical devices for indications not approved by the Food and Drug Administration.
    Smith JJ; Berlin L
    AJR Am J Roentgenol; 1999 Oct; 173(4):879-82. PubMed ID: 10511140
    [No Abstract]   [Full Text] [Related]  

  • 15. Liability for adverse drug reactions.
    Francisco CJ
    Tex Med; 1990 May; 86(5):42-6. PubMed ID: 2343420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal, regulatory issues impact AED (automatic external defibrillator) deployment.
    Lazar RA
    JEMS; 1997 Jan; 22(1):S21-2. PubMed ID: 10164242
    [No Abstract]   [Full Text] [Related]  

  • 18. The Pharmaceutical Access and Prudent Purchasing Act of 1990: Federal law shifts the duty to warn from the physician to the pharmacist.
    Holleran MJ
    Spec Law Dig Health Care (Mon); 1993 Dec; (178):9-30. PubMed ID: 10131324
    [No Abstract]   [Full Text] [Related]  

  • 19. The medicolegal aspects of adverse drug reactions.
    Bernstein HN; Levine AM
    Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801
    [No Abstract]   [Full Text] [Related]  

  • 20. Pedicle screws. Lack of FDA approval does not implicate use in hospital.
    West JC
    J Healthc Risk Manag; 1998; 18(2):53-5. PubMed ID: 10185080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.